PHARMACIE DAVOINE
ActiveSummary
PHARMACIE DAVOINE has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €144,505 and a net result of -€46,694. Equity has been stable since 2018 (±0.6% per year). Its solvency ranks better than 18% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Official details
Source: KBO- Status
- Active since 26-06-1991 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 2 others
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.053.733.686 5190 Jemeppe-sur-Sambre, since 29-08-2000
- Financial year end
- 31 December
- Peppol
- Reachable since 28-11-2025
Board and ownership
- CLAREXIS & CO SRLManaging director · permanent representative DAVOINE Alexis
- DAVOINE JEAN-CHRISTOPHEDirector · since 01-01-2021
- DAVOINE SRLDirector · since 25-08-2022
- DAVOINE90%· score 952025 annual accounts of DAVOINE
- Jean-Christophe Davoineannual accounts 2024
- Maria Barazzuttiannual accounts 2024
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.3%
- Gross margin
- €359,938
- ▼ 19.9%
- Turnover
- ≈ €1.3m
- estimated
- Loss
- €46,694
- Equity
- €144,505
- ▼ 24.4%
- Total assets
- €2.0m
- ▲ 20.0%
- Employees on 31-12-2025
- 5
- ▲ 25.0%
- 2025 accounts filed 30 days after the deadline
Score breakdownraises riskEquity €144,505 (7.3% of total assets)Liquidity: current ratio 0.85, cash €26,051, halvedSector: Retail trade (NACE 47)lowers riskSize: 3.5 FTE, total assets €2.0mShow the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 24% of them on solvency, 16% on liquidity, 24% on profitability and 18% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 51 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed 2 directors appointed, 2 directors resigningResignations: DAVOINE Clara (director) and DAVOINE Alexis (director) · Appointment: CLAREXIS & CO SRL (director) · Permanent representatives: DAVOINE Alexis and BARAZZUTTI Maria Teresa
- · Gazette deed Permanent representative: BARAZZUTTI Maria Teresa
- · Gazette deed Company renamed from PHARMANADINE to PHARMACIE DAVOINE
Comparable companies
These companies have the same main activity as PHARMACIE DAVOINE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.6m and €2.1m, founded between 1987 and 1998.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMACIE DAVOINE Vorst | €2.0m | €0.4m |
| HERZEEL Sint-Jans-Molenbeek | €1.9m | €0.4m |
| PHARMACIE DU PARVIS - VOORPLEIN APOTHEEK Sint-Pieters-Woluwe | €1.6m | €0.4m |
| APOTHEEK GODERIS & VINCENT Staden | €2.0m | €0.3m |
| FARMAGORA Ternat | €1.8m | €0.3m |
| APOTHEEK THEVISSEN-MEEUS Dilsen-Stokkem | €2.1m | €0.4m |
| Pharmacie de l'Europe Ottignies-Louvain-la-Neuve | €1.6m | €0.4m |
Key facts about PHARMACIE DAVOINE
- What is the company number of PHARMACIE DAVOINE?
- The company number of PHARMACIE DAVOINE is 0444.488.642. The VAT number is the same number with BE in front: BE 0444.488.642.
- Where is PHARMACIE DAVOINE based?
- The registered office is at Kastanjestraat 21, 1190 Vorst.Company details
- What does PHARMACIE DAVOINE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMACIE DAVOINE?
- The legal form of PHARMACIE DAVOINE is Public limited company (NV).
- When was PHARMACIE DAVOINE founded?
- PHARMACIE DAVOINE was founded on 26-06-1991.
- Is PHARMACIE DAVOINE still active?
- Yes, PHARMACIE DAVOINE is an active enterprise in the KBO register.
- How many employees does PHARMACIE DAVOINE have?
- PHARMACIE DAVOINE had an average of 3.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does PHARMACIE DAVOINE fall under?
- In its 2025 annual accounts, PHARMACIE DAVOINE states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of PHARMACIE DAVOINE?
- The turnover in financial year 2025 is ≈ €1.3m. This figure is estimated from the gross margin of €359,938 and 47 comparable companies (NACE 477). It probably lies between €1.0m and €2.2m.
- Is PHARMACIE DAVOINE profitable?
- In financial year 2025, PHARMACIE DAVOINE made a loss of €46,694.
- Where can I find the annual accounts of PHARMACIE DAVOINE?
- PHARMACIE DAVOINE filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACIE DAVOINE due?
- PHARMACIE DAVOINE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.